5,000 patients worldwide to help perfect cancer staging system

NCT ID NCT07013461

Recruiting now Knowledge-focused Sponsor: The University of Hong Kong-Shenzhen Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This international study aims to improve how doctors stage nasopharyngeal cancer by collecting data from 5,000 patients across multiple countries. Researchers will use this information to refine the TNM staging system and combine it with other factors like biomarkers. The goal is to help doctors personalize treatment more accurately. Participants will be followed for five years to track outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could lead to a more accurate staging system for nasopharyngeal cancer, helping doctors choose the best treatment for each patient and improving outcomes worldwide.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly benefit participants. The results depend on data quality and may take years to influence clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CANCINOMA (NPC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nasopharyngeal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NASOPHARYNGEAL CANCINOMA (NPC)

Contacts and locations

Locations

The University of Hong Kong-Shenzhen Hospital
RECRUITING

Shenzhen, Guangdong, 518009, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.